Neuralgia
Conditions
Brief summary
The purpose of this study is to obtain more data about efficacy and safety of the study drug Lyrica.
Interventions
None listed
Sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Study design
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Clinical diagnosis of peripheral or central neuropathic pain
Exclusion criteria
* None. Patients recruited by physician decision. Patient's personal data are not collected.
Outcome results
None listed